Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

26.53
Delayed Data
As of Jul 29
 -0.06 / -0.23%
Today’s Change
17.92
Today|||52-Week Range
70.40
-12.12%
Year-to-Date
Steven Cohen Buys AMAG Pharmaceuticals
Jul 29 / GuruFocus News - Paid Partner Content
Today's Perilous Reversal Stock: AMAG Pharmaceuticals (AMAG)
Jul 28 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close26.59
Today’s open26.68
Day’s range26.16 - 26.86
Volume372,430
Average volume (3 months)1,021,578
Market cap$930.2M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-82.73%
Earnings growth (this year)+465.09%
Earnings growth (next 5 years)-1.75%
Revenue growth (last year)+236.28%
P/E ratio74.0
Price/Sales2.55
Price/Book1.00

Competitors

 Today’s
change
Today’s
% change
VIVOMeridian Bioscience ...-0.64-3.20%
QDELQuidel Corp-0.44-1.89%
NTRANatera Inc-0.18-1.36%
AAAPAdvanced Accelerator...+0.29+0.94%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)$1.22
Annual revenue (last year)$418.3M
Annual profit (last year)$32.8M
Net profit margin7.84%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
William K. Heiden
President &
Chief Operating Officer
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs